延边医学
延邊醫學
연변의학
YAN BIAN YI XUE
2014年
20期
36-38
,共3页
美托洛尔%稳心颗粒%老年缺血性心律失常
美託洛爾%穩心顆粒%老年缺血性心律失常
미탁락이%은심과립%노년결혈성심률실상
metoprolol%Metacentric particles%Senile ischemic arrhythmias
目的：探究美托洛尔联合稳心颗粒治疗老年缺血性心律失常的临床治疗效果。方法：选取我院2011年4月~2013年4月门诊及住院部64例老年缺血性心律失常患者作为研究对象，按照治疗方法的不同分为实验组和对照组，对照组患者予以美托洛尔治疗，实验组患者在对照组的基础上加用稳心颗粒治疗，观察记录两组患者临床治疗效果及用药后不良反应情况。结果：两组患者经治疗后，临床疗效总有效率比较，实验组明显高于对照组，p＜0.05，差异具有统计学意义；两组患者用药后总不良反应率比较，实验组明显比对照组低，p＜0.05，差异具有统计学意义。结论：采取美托洛尔联合稳心颗粒治疗老年缺血性心律失常具有显著的临床治疗效果，可改善患者心律失常情况，且不良反应少、安全性高，是临床上治疗老年缺血性心律失常的首选方法。
目的：探究美託洛爾聯閤穩心顆粒治療老年缺血性心律失常的臨床治療效果。方法：選取我院2011年4月~2013年4月門診及住院部64例老年缺血性心律失常患者作為研究對象，按照治療方法的不同分為實驗組和對照組，對照組患者予以美託洛爾治療，實驗組患者在對照組的基礎上加用穩心顆粒治療，觀察記錄兩組患者臨床治療效果及用藥後不良反應情況。結果：兩組患者經治療後，臨床療效總有效率比較，實驗組明顯高于對照組，p＜0.05，差異具有統計學意義；兩組患者用藥後總不良反應率比較，實驗組明顯比對照組低，p＜0.05，差異具有統計學意義。結論：採取美託洛爾聯閤穩心顆粒治療老年缺血性心律失常具有顯著的臨床治療效果，可改善患者心律失常情況，且不良反應少、安全性高，是臨床上治療老年缺血性心律失常的首選方法。
목적：탐구미탁락이연합은심과립치료노년결혈성심률실상적림상치료효과。방법：선취아원2011년4월~2013년4월문진급주원부64례노년결혈성심률실상환자작위연구대상，안조치료방법적불동분위실험조화대조조，대조조환자여이미탁락이치료，실험조환자재대조조적기출상가용은심과립치료，관찰기록량조환자림상치료효과급용약후불량반응정황。결과：량조환자경치료후，림상료효총유효솔비교，실험조명현고우대조조，p＜0.05，차이구유통계학의의；량조환자용약후총불량반응솔비교，실험조명현비대조조저，p＜0.05，차이구유통계학의의。결론：채취미탁락이연합은심과립치료노년결혈성심률실상구유현저적림상치료효과，가개선환자심률실상정황，차불량반응소、안전성고，시림상상치료노년결혈성심률실상적수선방법。
objective to explore the metoprolol combined metacentre grain clinical treatment effect for the treatment of senile is-chemic arrhythmias. Methods select our hospital in April 2011~April 2013 outpatient and the inpatient 64 patients with senile ischemic arrhythmias as the research object, according to different divided into experimental group and the control group, treatment group pa-tients give metoprolol treatment, the experimental group patients in the control group treated with metacentric particles, on the basis of observation records in the two groups patients clinical therapeutic effect and drug adverse reactions after the situation. Results two groups of patients after treatment, the clinical curative effect of total effective rate comparison, the experimental group is significantly higher than the control group, p<0.05, the difference is statistically significant;Two groups of patients after total adverse reaction rate comparison, the experimental group was obviously lower than the control group, p<0.05, the difference is statistically significant. Conclusion taking metoprolol combined metacentric particles of senile ischemic arrhythmias has significant clinical effect, can improve patients with ar-rhythmia, and less adverse reaction, high safety, is clinically preferred method for the treatment of senile ischemic arrhythmias.
